Koji Kato

7.4k total citations
208 papers, 4.7k citations indexed

About

Koji Kato is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Koji Kato has authored 208 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 121 papers in Hematology, 59 papers in Public Health, Environmental and Occupational Health and 43 papers in Oncology. Recurrent topics in Koji Kato's work include Hematopoietic Stem Cell Transplantation (92 papers), Acute Lymphoblastic Leukemia research (57 papers) and Acute Myeloid Leukemia Research (52 papers). Koji Kato is often cited by papers focused on Hematopoietic Stem Cell Transplantation (92 papers), Acute Lymphoblastic Leukemia research (57 papers) and Acute Myeloid Leukemia Research (52 papers). Koji Kato collaborates with scholars based in Japan, United States and United Kingdom. Koji Kato's co-authors include Seiji Kojima, Takaharu Matsuyama, Hiroshi Kimura, Yoshiko Atsuta, Tsuneo Morishima, Keizo Horibe, Kiyotaka Kuzushima, Makoto Morita, Ritsuro Suzuki and Shunichi Kato and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and Blood.

In The Last Decade

Koji Kato

199 papers receiving 4.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Koji Kato Japan	34	2.2k	1.5k	1.0k	957	713	208	4.7k
Takehiko Mori Japan	40	2.2k 1.0×	1.3k 0.9×	1.2k 1.2×	932 1.0×	879 1.2×	303	5.0k
Shinichiro Okamoto Japan	41	3.3k 1.5×	1.5k 1.0×	875 0.9×	1.4k 1.5×	1.1k 1.5×	389	7.1k
Antonio Pagliuca United Kingdom	43	3.2k 1.4×	1.2k 0.8×	870 0.9×	645 0.7×	1.5k 2.1×	207	5.5k
Yoichi Takaue Japan	35	2.1k 1.0×	1.3k 0.9×	659 0.7×	528 0.6×	1.2k 1.7×	218	4.1k
Marie Robin France	43	3.3k 1.5×	1.0k 0.7×	1.1k 1.1×	644 0.7×	1.3k 1.9×	243	5.3k
Jonas Mattsson Sweden	44	3.7k 1.7×	1.9k 1.3×	1.0k 1.0×	776 0.8×	2.0k 2.8×	326	6.4k
Nathalie Dhédin France	29	1.4k 0.6×	905 0.6×	905 0.9×	352 0.4×	823 1.2×	127	3.2k
Yi‐Bin Chen United States	35	2.1k 1.0×	1.5k 1.0×	557 0.6×	561 0.6×	1.1k 1.6×	197	4.9k
Biju George India	37	2.8k 1.3×	751 0.5×	655 0.7×	964 1.0×	472 0.7×	299	5.0k
Pierre‐Simon Rohrlich France	33	906 0.4×	670 0.5×	658 0.7×	487 0.5×	1.1k 1.5×	138	3.5k

Countries citing papers authored by Koji Kato

Since Specialization

Citations

This map shows the geographic impact of Koji Kato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koji Kato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koji Kato more than expected).

Fields of papers citing papers by Koji Kato

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koji Kato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koji Kato. The network helps show where Koji Kato may publish in the future.

Co-authorship network of co-authors of Koji Kato

This figure shows the co-authorship network connecting the top 25 collaborators of Koji Kato. A scholar is included among the top collaborators of Koji Kato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koji Kato. Koji Kato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Miyanoiri, Yohei, Toshio Yamazaki, Tsutomu Terauchi, et al.. (2026). Unlabeled NMR Approach with Site-Specific Methyl Assignments for Structural Evaluation of the IgG1 Fc Region. Journal of the American Chemical Society. 148(8). 8374–8382.

Setoyama, Daiki, Kohta Miyawaki, Takuji Yamauchi, et al.. (2025). Cerebrospinal fluid proteomics exerts predictive potential for immune effector cell-associated neurotoxicity syndrome (ICANS) in CAR-T cell therapy. Leukemia. 39(4). 983–987.

Chau, Ian, Jaffer A. Ajani, Yuko Kitagawa, et al.. (2024). 398P Nivolumab (NIVO) plus chemotherapy (chemo) or ipilimumab (IPI) vs chemo as first-line (1L) treatment for advanced esophageal squamous cell carcinoma (ESCC): Additional analysies from 45-month (mo) follow-up of CheckMate 648. Annals of Oncology. 35. S161–S162.

Shimomura, Yoshimitsu, Tetsuhisa Kitamura, Makoto Murata, et al.. (2024). Impact of Center Volume on Chronic Graft Versus Host Disease in Patients With Allogeneic Stem Cell Transplantation. Transplantation and Cellular Therapy. 30(3). 326.e1–326.e14. 2 indexed citations

Kuwatsuka, Yachiyo, Rika Kasajima, Rui Yamaguchi, et al.. (2024). Machine Learning Prediction Model for Neutrophil Recovery after Unrelated Cord Blood Transplantation. Transplantation and Cellular Therapy. 30(4). 444.e1–444.e11. 1 indexed citations

Ishida, Hisashi, Toshihiko Imamura, Takashi Ishihara, et al.. (2023). Impact of asparaginase discontinuation on outcomes of children with acute lymphoblastic leukaemia receiving the Japan Association of Childhood Leukaemia Study ALL‐02 protocol. British Journal of Haematology. 201(6). 1200–1208. 4 indexed citations

Okinaka, Keiji, Yoshitaka Inoue, Naoyuki Uchida, et al.. (2023). Clinical characteristics and risk factors of pneumococcal diseases in recipients of allogeneic hematopoietic stem cell transplants in the late phase: A retrospective registry study. Journal of Infection and Chemotherapy. 29(7). 726–730. 3 indexed citations

Shimada, Hiroyuki, Akihiko Tanizawa, Takeshi Kondo, et al.. (2022). Prognostic Factors for Outcomes of Allogeneic HSCT for Children and Adolescents/Young Adults With CML in the TKI Era. Transplantation and Cellular Therapy. 28(7). 376–389. 3 indexed citations

Kanda, Junya, Katsutsugu Umeda, Koji Kato, et al.. (2020). Effect of graft-versus-host disease on outcomes after pediatric single cord blood transplantation. Bone Marrow Transplantation. 55(7). 1430–1437. 6 indexed citations

10.

Yoshida, Nao, Yoshiyuki Takahashi, Hiromasa Yabe, et al.. (2020). Conditioning regimen for allogeneic bone marrow transplantation in children with acquired bone marrow failure: fludarabine/melphalan vs. fludarabine/cyclophosphamide. Bone Marrow Transplantation. 55(7). 1272–1281. 5 indexed citations

11.

Okamoto, Yasuhiro, Yozo Nakazawa, Masami Inoue, et al.. (2020). Hematopoietic stem cell transplantation in children and adolescents with nonremission acute lymphoblastic leukemia. Pediatric Blood & Cancer. 67(12). e28732–e28732. 4 indexed citations

12.

Miyamura, Takako, Kazuko Kudo, Ken Tabuchi, et al.. (2019). Hematopoietic stem cell transplantation for pediatric acute myeloid leukemia patients with KMT2A rearrangement; A nationwide retrospective analysis in Japan. Leukemia Research. 87. 106263–106263. 6 indexed citations

13.

Okamoto, Yasuhiro, Kazuko Kudo, Ken Tabuchi, et al.. (2019). Hematopoietic stem-cell transplantation in children with refractory acute myeloid leukemia. Bone Marrow Transplantation. 54(9). 1489–1498. 10 indexed citations

14.

Hyakuna, Nobuyuki, Yoshiko Hashii, Hiroyuki Ishida, et al.. (2019). Retrospective analysis of children with high‐risk acute myeloid leukemia who underwent allogeneic hematopoietic stem cell transplantation following complete remission with initial induction chemotherapy in the AML‐05 clinical trial. Pediatric Blood & Cancer. 66(10). e27875–e27875. 8 indexed citations

15.

Fujita, Naoto, Ryōji Kobayashi, Yoshiko Atsuta, et al.. (2019). Hematopoietic stem cell transplantation in children and adolescents with relapsed or refractory B-cell non-Hodgkin lymphoma. International Journal of Hematology. 109(4). 483–490. 6 indexed citations

16.

Terakura, Seitaro, Kazuteru Ohashi, Takahiro Fukuda, et al.. (2019). Impacts of thymoglobulin in patients with acute leukemia in remission undergoing allogeneic HSCT from different donors. Blood Advances. 3(2). 105–115. 16 indexed citations

17.

Onishi, Yasushi, Takehiko Mori, Shinichi Kako, et al.. (2017). Outcome of Second Transplantation Using Umbilical Cord Blood for Graft Failure after Allogeneic Hematopoietic Stem Cell Transplantation for Aplastic Anemia. Biology of Blood and Marrow Transplantation. 23(12). 2137–2142. 15 indexed citations

18.

Yamamoto, Masaki, Tsukasa Hori, Naoki Hatakeyama, et al.. (2017). Early expression of serum CCL8 closely correlates to non-relapse mortality after allogeneic hematopoietic stem cell transplantation. Southern Medical Journal. 86. 45–51. 1 indexed citations

19.

Kato, Koji, Hiroyuki Kusuhara, Yuji Kumagai, et al.. (2012). Association of multidrug resistance-associated protein 2 single nucleotide polymorphism rs12762549 with the basal plasma levels of phase II metabolites of isoflavonoids in healthy Japanese individuals. Pharmacogenetics and Genomics. 22(5). 344–354. 16 indexed citations

20.

Matsuyama, Tomohiko, et al.. (2000). Bone marrow transplantation for children with acute myelogenous leukaemia in the first complete remission. European Journal of Cancer. 36(3). 368–375. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact